Efficacy Study of ABR-215050 to Treat Prostate Cancer
Condition(s):Prostate CancerLast Updated:October 26, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Prostate CancerLast Updated:October 26, 2015Completed
Condition(s):Breast Cancer; Multiple Myeloma; Prostate CancerLast Updated:February 1, 2012Completed
Condition(s):Prostatic NeoplasmsLast Updated:May 8, 2019Completed
Condition(s):Carcinoma ProstateLast Updated:March 4, 2022Unknown status
Condition(s):Metastatic Hormone-sensitive Prostate CancerLast Updated:October 26, 2022Active, not recruiting
Condition(s):Prostate Cancer; Castration Resistant Prostate Cancer; Pain; Prostatic NeoplasmsLast Updated:May 23, 2018Terminated
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:March 13, 2024Recruiting
Condition(s):Non Small Cell Lung Cancer With Bone MetastatsesLast Updated:February 2, 2021Completed
Condition(s):Prostate CancerLast Updated:June 28, 2017Unknown status
Condition(s):Metastatic Progressive Castration-resistant Prostate CancerLast Updated:October 23, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.